These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10963027)

  • 21. ICAAC. New resistance findings presented at annual conference.
    Rodriguez E
    Posit Living; 2002; 11(1):16. PubMed ID: 11942289
    [No Abstract]   [Full Text] [Related]  

  • 22. International perspectives on antiretroviral resistance. Introduction.
    Volberding P; Lange J
    J Acquir Immune Defic Syndr; 2001 Mar; 26 Suppl 1():S1-2. PubMed ID: 11265002
    [No Abstract]   [Full Text] [Related]  

  • 23. [Resistance investigations during HIV-therapy is necessary].
    Schattenfroh S
    Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversibility of HIV drug resistance.
    Davenport MP
    Science; 2000 May; 288(5470):1299. PubMed ID: 10847833
    [No Abstract]   [Full Text] [Related]  

  • 25. Viral resistance: a major challenge in managing HIV disease.
    Boucher CA; Reedijk M
    J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
    [No Abstract]   [Full Text] [Related]  

  • 26. [Human immunodeficiency virus and antiretroviral therapy resistance].
    Quirós E; Torti C; Carosi G
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
    [No Abstract]   [Full Text] [Related]  

  • 27. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
    Mascolini M; Wensing AM; Boucher CA
    IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306
    [No Abstract]   [Full Text] [Related]  

  • 28. 4th International Workshop on HIV Drug Resistance. Sardinia, Italy, July 6-9, 1995. Abstracts.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 3():S1-46. PubMed ID: 8605585
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacoresistance: an emerging clinical problem.
    Carosi G
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
    [No Abstract]   [Full Text] [Related]  

  • 30. Intention-to-treat analysis of anti-HIV therapies and incidence of drug resistance after a year of treatment.
    Aizawa S; Ida S; Sakai-Hachiya A; Tanaka M; Takahashi Y; Hirabayashi Y; Sugiura W; Kimura S; Oka S
    Jpn J Infect Dis; 1999 Jun; 52(3):129-31. PubMed ID: 10507996
    [No Abstract]   [Full Text] [Related]  

  • 31. [Light and shade on the treatment of HIV infection].
    Takata N
    Rinsho Ketsueki; 2001 Jun; 42(6):476-80. PubMed ID: 11505526
    [No Abstract]   [Full Text] [Related]  

  • 32. Nonadherence raises concerns over resistance.
    AIDS Alert; 1998 Sep; 13(9):108. PubMed ID: 11365793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV drug resistance.
    Voelker R
    JAMA; 2000 Jul; 284(2):169. PubMed ID: 10917789
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug clinics. How I treat HIV infections. II. Nucleoside reverse transcriptase inhibitors].
    Moutschen M; Nkoghe D; Léonard P; Demonty J
    Rev Med Liege; 1997 Dec; 52(12):750-2. PubMed ID: 9481171
    [No Abstract]   [Full Text] [Related]  

  • 35. AIDS 1998. Clinical treatment: overview.
    Vella S; Mildvan D
    AIDS; 1998; 12 Suppl A():S147-8. PubMed ID: 9632996
    [No Abstract]   [Full Text] [Related]  

  • 36. What is the difference between phenotyping and genotyping?
    Wilder TL
    Surviv News (Atlanta Ga); 2001 May; ():13, 20. PubMed ID: 11682727
    [No Abstract]   [Full Text] [Related]  

  • 37. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
    Soriano V; Briones C
    Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774
    [No Abstract]   [Full Text] [Related]  

  • 38. Putting resistance to the test.
    Daar ES
    Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369
    [No Abstract]   [Full Text] [Related]  

  • 39. [Monitoring anti-retroviral treatment].
    Miró JM; Pumarola T; Soriano V; Bouza E
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():44-50. PubMed ID: 9053027
    [No Abstract]   [Full Text] [Related]  

  • 40. Abstracts from the XVI International HIV Drug Resistance Workshop: Basic Principles and Clinical Implications. June 12-16, 2007. Barbados, West Indies.
    Antivir Ther; 2007; 12(5):P3-4, S3-174. PubMed ID: 17899670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.